Madame Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	170.26	80.19	34.34	252.69	41.26
Short-Term Investments	-	0.43	0.42	0.65	11.13
Cash & Short-Term Investments	170.26	80.62	34.76	253.34	52.39
Cash Growth	111.19%	131.96%	-86.28%	383.56%	-47.52%
Accounts Receivable	173.18	284.08	293.04	261.71	310.9
Other Receivables	-	57.6	42.64	49.17	35.98
Receivables	173.18	341.68	335.68	310.87	346.87
Inventory	47.04	142.02	237.64	280.56	361.82
Prepaid Expenses	-	8.11	8.77	7.44	12.71
Other Current Assets	9.47	12.93	17.86	29.81	66.65
Total Current Assets	399.95	585.35	634.7	882.03	840.44
Property, Plant & Equipment	357.09	675.01	943.3	1,015	624.97
Goodwill	323.3	241.08	241.08	429.05	77.47
Other Intangible Assets	107.28	62.49	67.83	73.34	5.33
Long-Term Deferred Tax Assets	-	0.53	1.67	7.25	5.58
Other Long-Term Assets	129.3	50.8	149.98	49.89	30.96
Total Assets	1,317	1,615	2,039	2,457	1,585
Accounts Payable	231.38	282.28	242.78	185.02	209.32
Accrued Expenses	0.63	70.34	82.52	47.29	78.1
Short-Term Debt	46.43	159.79	161.75	196.61	138.19
Current Portion of Long-Term Debt	42.66	239.46	363.51	61.86	31.55
Current Portion of Leases	4.34	15.98	18.67	24.95	22.28
Current Income Taxes Payable	1.34	-	-	-	-
Other Current Liabilities	0.19	57.7	66.44	63.73	64.74
Total Current Liabilities	326.97	825.54	935.67	579.47	544.18
Long-Term Debt	141.22	40.9	102.81	456.24	97.27
Long-Term Leases	8.97	158.02	172.92	182.25	33.88
Pension & Post-Retirement Benefits	10.69	29.42	25.07	23.46	14.97
Long-Term Deferred Tax Liabilities	33.19	20.3	23.02	24	5.83
Other Long-Term Liabilities	2.16	2.29	1.79	0.01	2.61
Total Liabilities	523.2	1,076	1,261	1,265	698.73
Common Stock	2,020	1,717	1,538	1,538	2,120
Additional Paid-In Capital	-225.6	-	59.43	59.43	-
Retained Earnings	-1,078	-1,137	-810.61	-403.84	-1,028
Comprehensive Income & Other	32.43	-84.86	-49.19	-49.19	-177.68
Total Common Equity	748.53	495.51	737.83	1,145	914.1
Minority Interest	45.19	43.3	39.46	46.75	-28.08
Shareholders' Equity	793.72	538.8	777.28	1,191	886.03
Total Liabilities & Equity	1,317	1,615	2,039	2,457	1,585
Total Debt	243.62	614.14	819.66	921.92	323.17
Net Cash (Debt)	-73.36	-533.52	-784.91	-668.57	-270.78
Net Cash Per Share	-0.02	-0.86	-1.28	-1.11	-0.68
Filing Date Shares Outstanding	4,039	686.8	615.28	615.28	423.93
Total Common Shares Outstanding	4,039	686.8	615.28	615.28	423.93
Working Capital	72.98	-240.19	-300.97	302.56	296.27
Book Value Per Share	0.19	0.72	1.20	1.86	2.16
Tangible Book Value	317.95	191.94	428.92	642.21	831.3
Tangible Book Value Per Share	0.08	0.28	0.70	1.04	1.96
Land	-	94.65	93.68	93.68	68.66
Buildings	-	365.39	464.49	450.88	164.24
Machinery	-	541.77	861.78	908.65	640.66
Construction In Progress	-	4.08	7.91	12.97	150.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.